Latest Induced pluripotent stem cell therapy Stories
Newly developed test can identify sickle cell disease in minutes and could be used in rural clinics around the globe
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Biologists reveal genes key to development of pluripotency, in single cells
- A trick or prank.